Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry

TerminatedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

August 6, 2018

Primary Completion Date

May 14, 2020

Study Completion Date

May 14, 2020

Conditions
Hemophilia A
Interventions
DRUG

New FVIII products

Kovaltry or Jivi prescribed by the treating Physician

Trial Locations (27)

10065

Weill Cornell Medicine, New York

14621

Mary M. Gooley Hemophilia Center, Inc., Rochester

15213

Hemophilia Center of Western Pennsylvania, Pittsburgh

19104

Penn Comprehensive Hemophilia and Thrombophilia Program / Hospital UPENN, Philadelphia

20010

Children's National Medical Center, Washington D.C.

21205

The Johns Hopkins University Hemophilia Treatment Center, Baltimore

30322

Emory / Children's Healthcare of Atlanta, Atlanta

33607

St. Josephs Hemophilia Treatment Center, Tampa

33701

Johns Hopkins All Children's Hospital, St. Petersburg

38105

St. Jude Children's Research Hospital, Memphis

46260

Indiana Hemophilia and Thrombosis Center IHTC, Indianapolis

48109

Univ of Michigan Hemophilia and Coagulation Disorders, Ann Arbor

48824

Michigan State University Center for Bleeding Disorders & Clotting Disorders, East Lansing

53226

Blood Center of Wisconsin, Inc. /Childrens Hosp of Wisconsin, Milwaukee

61615

Bleeding and Clotting Disorders Institute, Peoria

64108

Children's Mercy Hospital (Kansas City), Kansas City

70112

Louisiana Center for Bleeding and Clotting Disorders / Tulane, New Orleans

75390

UT Southwestern/Children's Health Dallas, Dallas

80045

University of Colorado Denver Hemophilia and Thrombosis Center, Aurora

92093

University of California, San Diego, La Jolla

97239

Oregon Health & Science University, Portland

98104

BloodWorks (Puget Sound), Seattle

06510

Yale Hemophilia Treatment Center, New Haven

04074

Maine Hemophilia and Thrombosis Center, Scarborough

02115

Boston Hemophilia Center at Children's Hospital of Boston/Brigham Women's, Boston

03756

Dartmouth-Hitchcock Comprehensive Hemophilia and Thrombosis Center, Lebanon

01914

Children's Hospital of Philadelphia (CHOP), Philadelphia

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

American Thrombosis and Hemostasis Network

NETWORK

lead

Bayer

INDUSTRY

NCT03603275 - Assessing Physician and Hemophilia A Patient Reasons and Expectations for Switching Treatment to Kovaltry & Jivi: A Nested Study Within an Existing Registry | Biotech Hunter | Biotech Hunter